Brukinsa 80 mg

BRUKINSA 80 MG capsules contain zanubrutinib, a medication used for certain types of cancer. This oral treatment is designed to target specific proteins in the body, supporting cancer therapy. Learn more about BRUKINSA 80 MG uses and effects.

BRUKINSA 80 MG capsules are primarily used in the treatment of specific cancers, such as mantle cell lymphoma and Waldenström's macroglobulinemia. Zanubrutinib, the active ingredient, works by inhibiting certain proteins involved in cancer cell growth. This medication is often prescribed as part of a broader cancer treatment plan, aiming to slow down or stop the progression of the disease. Patients should consult their healthcare provider to understand what BRUKINSA 80 MG is used for in their specific case.

Common effects of BRUKINSA 80 MG capsules may include fatigue, diarrhea, and upper respiratory tract infections. Some users might experience bruising or bleeding more easily. It's important to monitor for any unusual symptoms and discuss them with a healthcare professional. The effects can vary from person to person, and not everyone will experience the same side effects.

BRUKINSA 80 MG capsules should be handled with care, following the instructions provided by a healthcare professional. It is important to store the medication properly and to take it exactly as prescribed. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their doctor.

BRUKINSA 80 MG capsules may interact with certain medications, including those that affect liver enzymes like CYP3A. Alcohol and other substances that can cause drowsiness should be avoided. Patients should always inform their healthcare provider about all the medications they are taking to ensure safe and effective treatment. It's crucial to follow medical advice regarding potential interactions.